J&J does Alzheimer’s gene therapy deal, along with 14 other new collaborations – Endpoints News
Endpoints News |
J&J does Alzheimer's gene therapy deal, along with 14 other new collaborations
Endpoints News Johnson & Johnson has inked a research deal with University of Pennsylvania to work on gene therapy for Alzheimer's. The partnership leverages the university's adeno-associated viruses and J&J's anti-Alzheimer's antibodies in hopes to penetrate the … |
